References
- Sargent DJ, Wieand HS, Haller DG, Gray R, Benedetti JK, Buyse M, Labianca R, Seitz JF, O’Callaghan CJ, Francini G, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol. 2005;23(34):8664–8670.:doi:https://doi.org/10.1200/jco.2005.01.6071
- Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141(1):67–75.: doi:https://doi.org/10.1016/j.surg.2006.07.020
- O’Connell MJ, Campbell ME, Goldberg RM, Grothey A, Seitz J-F, Benedetti JK, André T, Haller DG, Sargent DJ. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set. J Clin Oncol. 2008;26(14):2336–2341. doi:https://doi.org/10.1200/jco.2007.15.8261
- Weiser MR, Landmann RG, Kattan MW, Gonen M, Shia J, Chou J, Paty PB, Guillem JG, Temple LK, Schrag D, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26(3):380–385.:doi:https://doi.org/10.1200/jco.2007.14.1291
- McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:https://doi.org/10.1016/j.ctrv.2012.08.003
- Gomez D, Morris-Stiff G, Wyatt J, Toogood GJ, Lodge JPA, Prasad KR. Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol. 2008;98(5):371–376. doi:https://doi.org/10.1002/jso.21103
- Dimitriou N, Felekouras E, Karavokyros I, Alexandrou A, Pikoulis E, Griniatsos J. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. BMC Cancer. 2018;18(1):1202 doi:https://doi.org/10.1186/s12885-018-5042-x
- Li M-X, Liu X-M, Zhang X-F, Zhang J-F, Wang W-L, Zhu Y, Dong J, Cheng J-W, Liu Z-W, Ma L, et al. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134(10):2403–2413.:doi:https://doi.org/10.1002/ijc.28536
- Chan JCY, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, Clarke SJ. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539–546. doi:https://doi.org/10.1097/SLA.0000000000001743
- Guo Y-H, Sun H-F, Zhang Y-B, Liao Z-J, Zhao L, Cui J, Wu T, Lu J-R, Nan K-J, Wang S-H, et al. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis. Oncotarget. 2017;8(12):20011–20024. doi:https://doi.org/10.18632/oncotarget.15311
- He W, Yin C, Guo G, Jiang C, Wang F, Qiu H, Chen X, Rong R, Zhang B, Xia L, et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol. 2013;30(1):439.: doi:https://doi.org/10.1007/s12032-012-0439-x
- Lee S-H, Lee J, Park J, Park SH, Lee K-E, Lee SI, Nam E, Park JO, Kim K, Jung CW, et al. Capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer. Med Oncol. 2004;21(3):223–231.: doi:https://doi.org/10.1385/MO:21:3:223
- McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007;22(8):881–886. doi:https://doi.org/10.1007/s00384-006-0259-6
- Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2009;100(8):1236–1239. doi:https://doi.org/10.1038/sj.bjc.6604997
- Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K. Prognostic significance of the preoperative ratio of c-reactive protein to albumin in patients with colorectal cancer. Anticancer Res. 2016;36(3):995–1001.
- Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the C-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23(3):900–909. doi:https://doi.org/10.1245/s10434-015-4948-7
- Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum. 2015;58(11):1048–1057. doi:https://doi.org/10.1097/DCR.0000000000000458
- Tominaga T, Nonaka T, Hisanaga M, Fukuda A, Tanoue Y, Yoshimoto T, Hidaka S, Sawai T, Nagayasu T. Prognostic value of the preoperative prognostic nutritional index in oldest-old patients with colorectal cancer. Surg Today. 2020;50(5):449–459. doi:https://doi.org/10.1007/s00595-019-01910-w
- Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, et al. Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One. 2015;10(7):e0132488:doi:https://doi.org/10.1371/journal.pone.0132488
- Ahiko Y, Shida D, Horie T, Tanabe T, Takamizawa Y, Sakamoto R, Moritani K, Tsukamoto S, Kanemitsu Y. Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer. BMC Cancer. 2019;19(1):946 doi:https://doi.org/10.1186/s12885-019-6218-8
- Kanemitsu Y, Shida D, Tsukamoto S, Ueno H, Ishiguro M, Ishihara S, Komori K, Sugihara K. Nomograms predicting survival and recurrence in colonic cancer in the era of complete mesocolic excision. BJS Open. 2019;3(4):539–548. doi:https://doi.org/10.1002/bjs5.50167
- Konishi T, Shimada Y, Hsu M, Wei IH, Pappou E, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, et al. Contemporary validation of a nomogram predicting colon cancer recurrence, revealing all-stage improved outcomes. JNCI Cancer Spectr. 2019;3(2):pkz015:doi:https://doi.org/10.1093/jncics/pkz015
- Zhou Z, Mo S, Dai W, Xiang W, Han L, Li Q, Wang R, Liu L, Zhang L, Cai S, et al. Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study. Cancer Cell Int. 2019;19:355:doi:https://doi.org/10.1186/s12935-019-1079-4
- Guo G, Chen X, He W, Wang H, Wang Y, Hu P, Rong Y, Fan L, Xia L. Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data. PLoS One. 2018;13(12):e0208547. doi:https://doi.org/10.1371/journal.pone.0208547
- Harrell FE, Jr., Califf RM, Pryor DB, Lee KL, Rosati RA. Evaluating the yield of medical tests. JAMA. 1982;247(18):2543–2546. doi:https://doi.org/10.1001/jama.1982.03320430047030
- Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, et al. NCCN guidelines insights: colon cancer, version 2.2018. J Natl Compr Canc Netw. 2018;16(4):359–369.:doi:https://doi.org/10.6004/jnccn.2018.0021
- Foxtrot Collaborative G. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012;13:1152–1160. doi:https://doi.org/10.1016/s1470-2045(12)70348-0
- Martin B, Schäfer E, Jakubowicz E, Mayr P, Ihringer R, Anthuber M, Schenkirsch G, Schaller T, Märkl B. Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance? Virchows Arch. 2018;473(2):189–197. doi:https://doi.org/10.1007/s00428-018-2341-1
- Schneider NI, Langner C. Prognostic stratification of colorectal cancer patients: current perspectives. Cancer Manag Res. 2014;6:291–300. doi:https://doi.org/10.2147/cmar.S38827
- Hyodo I, Suzuki H, Takahashi K, Saito Y, Tanaka S, Chiu H-M, Kim NK, Li J, Lim R, Villalon A, et al. Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol. 2010;40(Suppl 1):i38–i43.:doi:https://doi.org/10.1093/jjco/hyq125
- Mo S, Dai W, Xiang W, Li Y, Feng Y, Zhang L, Li Q, Cai G. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer. Carcinogenesis. 2019;40(7):861–870. doi:https://doi.org/10.1093/carcin/bgz031
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–867. doi:https://doi.org/10.1038/nature01322
- McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–226. doi:https://doi.org/10.1097/MCO.0b013e32832a7902
- Sellitto A, Galizia G, De Fanis U, Lieto E, Zamboli A, Orditura M, De Vita F, Giunta R, Lucivero G, Romano C, et al. Behavior of circulating CD4 + CD25 + Foxp3+ regulatory T cells in colon cancer patients undergoing surgery. J Clin Immunol. 2011;31(6):1095–1104.:doi:https://doi.org/10.1007/s10875-011-9585-8
- Chua W, Charles KA, Baracos VE, Clarke SJ. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer. 2011;104(8):1288–1295. doi:https://doi.org/10.1038/bjc.2011.100
- Ueno H, Hawrylowicz CM, Banchereau J. Immunological intervention in human diseases. J Transl Med. 2007;5:59 doi:https://doi.org/10.1186/1479-5876-5-59
- Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:https://doi.org/10.1200/jco.2007.12.9791
- Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102:5–14.
- Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi:https://doi.org/10.1016/j.cell.2010.01.025
- Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181–184. doi:https://doi.org/10.1002/jso.20329